| European photonics scientists are developing an ultrasensitive laser sensor that detects coronavirus at the earliest point of infection from a saliva or nasal swab in minutes. | |
| Responding to the European Commission’s Express Calls to tackle the coronavirus pandemic, photonics scientists are developing a new rapid, non-invasive ‘optical biosensor’ demonstrator that will detect Covid-19 in humans as soon as it is present in the body. | |
| Having already created six working laboratory demonstrators for other applications, the research team says the technology still needs further adaptation and testing but could be available in a year at the latest. | |
| Originally developed to look for bacterial infections or cancer biomarkers, the new ultrasensitive detector uses photonics – technology that manipulates light – to detect infections in patients with a small amount of the virus. |
| With the ability to diagnose in real-time with high specificity from a low concentration sample, the sensor is much more reliable than the coronavirus rapid-test, ‘finger-prick’ kit which detects if a person has had the coronavirus before and has since recovered. | |
| Looking at tiny molecules, the new point-of-care detector examines virus antigens using miniaturised chips – or ‘nanophotonic biosensors’ – from a simple nasal or saliva swab. | |
| Once a sample is prepared and is in place, the device confirms a positive or negative for coronavirus instantaneously. However, allowing for preparation time and analysis, a result – from sample to diagnosis – may take up to 30 minutes. | |
Testing |
|
| Calling themselves CONVAT and coordinated at ‘ICN2’ (the Catalan Institute of Nanoscience and Nanotechnology, Spain) the researchers have tested the demonstrators on patients’ samples provided by Vall D´Hebrón Hospital in Barcelona and several other hospitals in Spain for other pathologies. | |
| Project coordinator, Professor Laura Lechuga said: “With thousands of deaths worldwide, we are in urgent need of a rapid new testing kit that is accurate, highly sensitive, non-invasive and cheap to produce”. | |
| “We are currently integrating all the instrumentation in a portable 25x15x25 cm box with a tablet control. At present, our detector is user-friendly, with the preparation being only technical expertise required, and could be widely deployed for GPs or nurses to test patients.” | |
| “Our nanosensor is capable of detecting RNA strands which will fully identify the new coronavirus.” |
Image Credit: AP
News This Week
Research finds a potential new ‘silver bullet’ nanoparticle to treat brain cancer
ANSTO has contributed to a comprehensive investigation of a promising type of nanoparticle that could potentially be used for intractable brain cancers in a combined therapy. The study, which was led by Dr. Moeava [...]
Trial to study effect of immune system on Covid reinfection
The immune response needed to protect people against reinfection with the coronavirus will be explored in a new human challenge trial, researchers have revealed. Human challenge trials involve deliberately exposing healthy people to a [...]
Duke working on developing flu shot using new CoV vaccine technology
Researchers from Duke University are developing a flu shot with the new technology that was used for two coronavirus vaccines. Both the Pfizer-BioNTech and the Moderna shots use part of the virus's genetic code [...]
Long-acting injectable medicine as potential route to COVID-19 therapy
Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19. In a paper published in the journal Nanoscale, [...]
Superbug killer: New nanotech destroys bacteria and fungal cells
Researchers have developed a new superbug-destroying coating that could be used on wound dressings and implants to prevent and treat potentially deadly bacterial and fungal infections. The material is one of the thinnest antimicrobial [...]
US recommends ‘pause’ for J&J vaccine over clot reports
The U.S. is recommending a "pause" in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. In a joint statement Tuesday, the Centers for Disease Control [...]
S. African COVID variant better at bypassing Pfizer/BioNTech jab: Israeli study
The South African coronavirus variant is better at "breaking through" the defences of the Pfizer/BioNTech vaccine than other forms of the virus, Israeli experts said Sunday. However, one of the authors told AFP that [...]
Artificial intelligence to explore the biomolecular world
EPFL scientists have developed AI-powered nanosensors that let researchers track various kinds of biological molecules without disturbing them. The tiny world of biomolecules is rich in fascinating interactions between a plethora of different agents [...]
Why SARS-CoV-2 replicates better in the upper respiratory tract
A team of researchers from the Institute for Infectious Diseases (IFIK) at the University of Bern and the Federal Institute of Virology and Immunology (IVI) have assessed virus growth and activation of the cellular [...]
Brown University creates first wireless, implanted brain-computer interface
Researchers at Brown University have succeeded in creating the first wireless, implantable, rechargeable, long-term brain-computer interface. The wireless BCIs have been implanted in pigs and monkeys for over 13 months without issue, and human [...]
A New Generation of Vaccines Is Coming, Some With No Needles
The coronavirus outbreak made household names of companies like Moderna Inc. and BioNTech SE, whose shots offered hope for ending the pandemic. Now a new wave of vaccines is on the horizon that may get the [...]
Scientists use nanotechnology to detect bone-healing stem cells
Researchers at the University of Southampton have developed a new way of using nanomaterials to identify and enrich skeletal stem cells—a discovery which could eventually lead to new treatments for major bone fractures and [...]
Biotech start-up working overtime to develop a mutation-resistant Covid-19 vaccine
In March 2020, Hannu Rajaniemi pivoted his biotech company Helix Nanotechnologies' focus from cancer therapies to Covid-19 vaccines. The role biotech start-ups can play in a pandemic Rajaniemi originally co-founded Helix Nanotechnologies in Cambridge, Massachusetts in [...]
Nanotech-powered testing strategy can accelerate global recovery from pandemic
The rapid mass testing strategy costing just £1 a day per child can get children back to school and economies up and running, according to experts. That is the small price of the [...]
Nasal Spray Vaccine Could Be Key to Stopping the Spread of Covid-19
Covid-19 vaccines are incredibly good at preventing severe symptoms and hospitalization, but they’re probably less effective at stopping transmission. To do that, we might need a different kind of vaccine altogether. Because SARS-CoV-2 is [...]
Did coronavirus leak from a lab? These scientists say we shouldn’t rule it out
For many scientists, challenging the idea that SARS-CoV-2 has natural origins is seen as career suicide. But a vocal few say it shouldn't be disregarded or lumped in with conspiracy theories. Nikolai Petrovsky was scrolling [...]
